Strata Critical Medical, Inc. SRTA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 280.76M | 255.98M | 228.58M | 197.14M | 166.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 280.76M | 255.98M | 228.58M | 197.14M | 166.74M |
| Cost of Revenue | 222.94M | 204.32M | 183.13M | 158.76M | 135.01M |
| Gross Profit | 57.82M | 51.66M | 45.45M | 38.38M | 31.73M |
| SG&A Expenses | 56.18M | 51.43M | 51.53M | 49.31M | 50.78M |
| Depreciation & Amortization | 16.23M | 11.08M | 4.81M | 3.73M | 2.39M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 293.99M | 265.47M | 238.12M | 210.44M | 187.15M |
| Operating Income | -13.23M | -9.50M | -9.54M | -13.30M | -20.41M |
| Income Before Tax | -21.12M | -23.16M | -16.05M | -20.07M | -22.11M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.12 | -23.16 | -16.05 | -20.07 | -22.11 |
| Earnings from Discontinued Operations | -3.69M | 63.38M | 63.05M | 61.41M | 62.50M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.81M | 40.22M | 46.99M | 41.35M | 40.39M |
| EBIT | -13.23M | -9.50M | -9.54M | -13.30M | -20.41M |
| EBITDA | 8.66M | 6.53M | -802.00K | -6.40M | -15.44M |
| EPS Basic | -0.29 | 0.50 | 0.57 | 0.50 | 0.48 |
| Normalized Basic EPS | -0.06 | -0.03 | -0.02 | -0.04 | -0.12 |
| EPS Diluted | -0.29 | 0.49 | 0.57 | 0.50 | 0.47 |
| Normalized Diluted EPS | -0.06 | -0.03 | -0.02 | -0.04 | -0.12 |
| Average Basic Shares Outstanding | 344.51M | 338.69M | 333.77M | 328.34M | 322.19M |
| Average Diluted Shares Outstanding | 349.35M | 343.54M | 338.62M | 328.34M | 322.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |